Has Chinwe Mueller received payments from drug or device companies?

Yes. Drug and device makers reported $51,674 in general payments to Chinwe Mueller across 263 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chinwe Mueller did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chinwe Mueller come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chinwe Mueller

Registered Nurse · Washington, DCNPI 1316297427

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 77.1% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $22,677, 8.6 times the $2,641 reported in 2021.

$51,674in general payments, 2019–2025

Across 263 payments — averaging $196.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$40K
Atricure, Inc.$6K
Abbott$2K
Medtronic$2K
Biotronik Inc.$1K
Biosense Webster, Inc.$396
plus $662 from 5 others

What the payments were for

Speaking & faculty fees$28,00054%
Travel & lodging$12,12823%
Food & beverage$11,53922%
Education$70%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	111	$39,845
Atricure, Inc.	33	$5,732
Abbott	48	$2,202
Medtronic	34	$1,747
Biotronik Inc.	15	$1,090
Biosense Webster, Inc.	6	$396
Philips North America LLC	7	$282
Novo Nordisk	6	$238
Cardiofocus, Inc.	1	$102
Johnson & Johnson	1	$23
E.r. Squibb & Sons, L.L.C.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

WATCHMAN Access System$31,068
Watchman$5,794
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$3,585
SYNERGY ABLATION SYSTEM$2,527
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$1,668
WATCHMAN FLX$899
Acticor$805
Edora$805
BioMonitor$805
Solia$805
Rivacor$805
LINQ II$434
AVEIR$426
Micra$309
COBALT DR MRI SURESCAN$289
Carto 3$237
CLINICAL TRIAL PRODUCT$180
Fortify Assura, Ellipse ICD$179
FARAWAVE$162
Agilis NxT EP Introducer$158

How this compares

Too few registered nurse providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	110	$138,214
XareltoRivaroxaban	40	$54,839
MultaqDronedarone Hcl	24	$34,981
Amiodarone Hcl	29	$1,247
Flecainide Acetate	21	$672
Metoprolol Succinate	35	$665
ClopidogrelClopidogrel Bisulfate	28	$447

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonXarelto	$23	$54,83940 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few registered nurse providers in District of Columbiaon file to place this against a meaningful peer group, so we don't.

Other registered nurse in Washington

Nancy TwitchelWashington$1K
Bola AhmedWashington$357
Tanashia ThomasWashington$258
Brianna JenningsWashington$155
Chidinma UwakweWashington$120
Georgette DeyonouWashington$102
Amy WoodyWashington$102
Doris DibiaWashington$79
Stefanie KellyWashington$41
Susan BourgeoisWashington$32

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →